Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Samuel F Hunter, Jas Bindra, Ishveen Chopra, John Niewoehner, Mary P Panaccio & George J Wan. (2021) Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis. ClinicoEconomics and Outcomes Research 13, pages 883-892.
Read now
Read now
Articles from other publishers (12)
Constance Nève de Mévergnies, Nick Verhaeghe, Ernst H W Koster, Chris Baeken, Yannick Vander Zwalmen & Kristof Hoorelbeke. (2023) Health Economic Evaluation of Cognitive Control Training for Depression: Key Considerations. JMIR Mental Health 10, pages e44679.
Crossref
Crossref
Sónia Romano, Débora Figueira, Inês Teixeira & Julian Perelman. (2021) Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations. PharmacoEconomics 40:3, pages 269-295.
Crossref
Crossref
Marta Ortega‐Ortega, Paul Hanly, Alison Pearce, Isabelle Soerjomataram & Linda Sharp. (2021) Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer 150:4, pages 580-593.
Crossref
Crossref
Wei Dai, Erica Craig, Brent Fraser, Alex Chambers, Helen Mai, M. Brown, Craig Earle, William Evans, Marc Geirnaert, Marianne Taylor, Maureen Trudeau, Daniel Sperber, Jaclyn Beca, Avram Denburg, Rebecca Mercer, Ambica Parmar, Mina Tadrous, Pam Takhar & Kelvin Chan. (2021) Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise. Current Oncology 28:6, pages 4645-4654.
Crossref
Crossref
Jie Jiang, Yanming Hong, Tiantian Zhang, Zhihao Yang, Tengfei Lin, Zhuoru Liang, Peiyao Lu, Lishun Liu, Binyan Wang, Yongmei Xu & Nan Luo. (2021) Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Quality of Life Research 30:7, pages 2045-2060.
Crossref
Crossref
Renske M.T. ten Ham, Olaf H. Klungel, Hubert G.M. Leufkens & Geert W.J. Frederix. (2020) A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature. Value in Health 23:9, pages 1268-1280.
Crossref
Crossref
Carla Guerriero, Neus Abrines Jaume, Karla Diaz-Ordaz, Katherine Loraine Brown, Jo Wray, Joan Ashworth, Matt Abbiss & John Cairns. (2019) Using Animation to Self-Report Health: A Randomized Experiment with Children. The Patient - Patient-Centered Outcomes Research 13:2, pages 175-188.
Crossref
Crossref
Jan Schildmann. (2019) Value and Values in Cancer Care. Assessing the Benefit of Treatment in Patients with Advanced Cancer. Oncology Research and Treatment 42:1-2, pages 35-40.
Crossref
Crossref
Szymon Jarosławski, Eve Hanna, Monique Dabbous, Lylia Chachoua & Mondher Toumi. 2019. Regulatory and Economic Aspects in Oncology. Regulatory and Economic Aspects in Oncology
39
55
.
Jean-Hugues Salmon, Anne-Christine Rat, Isabelle Charlot-Lambrecht, Jean-Paul Eschard, Damien Jolly & Bruno Fautrel. (2018) Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis. PharmacoEconomics 36:11, pages 1321-1331.
Crossref
Crossref
William C. N. Dunlop, Nicola Mason, James Kenworthy & Ron L. Akehurst. (2016) Benefits, Challenges and Potential Strategies of Open Source Health Economic Models. PharmacoEconomics 35:1, pages 125-128.
Crossref
Crossref
Jonathan Karnon & Andrew Partington. (2015) Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?. PharmacoEconomics 33:12, pages 1281-1288.
Crossref
Crossref